TAKASHI KAMIGAKI

カミガキタカシ | TAKASHI KAMIGAKI

Affiliation and department：
Job title： Lecturer
Homepage URL (1)： https://www.juntendo.ac.jp/graduate/laboratory/labo/next-i/

Research keywords (6)：再生医療 , 消化器外科学 , 細胞療法 , 免疫療法 , 腫瘍学 , oncology gastrointestinal surgery

Research theme for competitive and other funds (9)：

2023 - 2026 Immunological analysis and POC establishment of comprehensive neoantigen-specific immunotherapy for cold tumor
2019 - 2022 Development of comprehensive cancer immunotherapy using PD-1 positive tumor specific T lymphocytes
2016 - 2019 Elucidation of the mechanism of immune activation and identification of novel target molecules associated with allogeneic reactions
2015 - 2018 Establishment of postoperative adjuvant immunotherapy using peptide pool of tumor antigens in advanced esophageal cancer
2013 - 2016 Development of cancer treatment harnessing NKT cells with a cross-talk of innate and acquired immunity

Show all

Papers (109)：

Takashi Kamigaki, Rishu Takimoto, Sachiko Okada, Hiroshi Ibe, Eri Oguma, Shigenori Goto. Personalized Dendritic-cell-based Vaccines Targeting Cancer Neoantigens. Anticancer research. 2024. 44. 9. 3713-3724
Yu Okazawa, Takashi Kamigaki, Kiichi Sugimoto, Takeshi Yamada, Yoichiro Yoshida, Sachiko Okada, Hiroshi Ibe, Eri Oguma, Takuma Iwai, Akihisa Matsuda, et al. A pilot study on the safety and efficacy of neoadjuvant chemo-adoptive immunotherapy for locally advanced rectal cancer. Oncology letters. 2024. 27. 3. 101-101
Akihiko Kida, Eishiro Mizukoshi, Masaaki Kitahara, Tomoharu Miyashita, Shigenori Goto, Takashi Kamigaki, Rishu Takimoto, Jun Asai, Kaheita Kakinoki, Takeshi Urabe, et al. Effects of adoptive T-cell immunotherapy on immune cell profiles and prognosis of patients with unresectable or recurrent cholangiocarcinoma. International journal of cancer. 2024. 154. 4. 738-747
Rishu Takimoto, Takashi Kamigaki, Hisao Ito, Masashi Saito, Ken Takizawa, Kenzo Soejima, Hiroyuki Yasuda, Keiko Ohgino, Hideki Terai, Katsuro Tomita, et al. Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG). Cytotherapy. 2023. 25. 11. 1229-1235
Rishu Takimoto, Takashi Kamigaki, Sachiko Okada, Hiroshi Ibe, Eri Oguma, Shigenori Goto. Efficacy of Adjuvant Immune-cell Therapy Combined With Systemic Therapy for Solid Tumors. Anticancer research. 2022. 42. 8. 4179-4187

ｍore...

MISC (173)：

ｍore...

Patents (3)：

Lectures and oral presentations (286)：

ｍore...

Professional career (1)：

Work history (4)：

Association Membership(s) (4)：

日本消化器病学会 , 日本臨床腫瘍学会 , 日本癌治療学会 , 日本癌学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page